These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38634292)

  • 1. Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT).
    Garg R; D'Agostino RB; O'Connell N; Lesser GJ; Salloum FN; Hines AL; Meléndez GC; Jordan JH; Ky B; Wagner LI; Sutton AL; Bottinor W; Olson KC; Ladd AC; Hundley WG;
    Hypertension; 2024 Jun; 81(6):1365-1373. PubMed ID: 38634292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
    Dang C; Guo H; Najita J; Yardley D; Marcom K; Albain K; Rugo H; Miller K; Ellis M; Shapira I; Wolff AC; Carey LA; Moy B; Groarke J; Moslehi J; Krop I; Burstein HJ; Hudis C; Winer EP; Tolaney SM
    JAMA Oncol; 2016 Jan; 2(1):29-36. PubMed ID: 26539793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.
    Meléndez GC; Sukpraphrute B; D'Agostino RB; Jordan JH; Klepin HD; Ellis L; Lamar Z; Vasu S; Lesser G; Burke GL; Weaver KE; Ntim WO; Hundley WG
    Am J Cardiol; 2017 May; 119(10):1637-1642. PubMed ID: 28341361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2-Year Postchemotherapy Measures of Left Ventricular Ejection Fraction.
    Suerken CK; D'Agostino RB; Jordan JH; Meléndez GC; Vasu S; Lamar ZS; Hundley WG
    J Am Heart Assoc; 2020 Jan; 9(2):e015400. PubMed ID: 31959033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function.
    Chotenimitkhun R; D'Agostino R; Lawrence JA; Hamilton CA; Jordan JH; Vasu S; Lash TL; Yeboah J; Herrington DM; Hundley WG
    Can J Cardiol; 2015 Mar; 31(3):302-7. PubMed ID: 25662284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol.
    Heck SL; Mecinaj A; Ree AH; Hoffmann P; Schulz-Menger J; Fagerland MW; Gravdehaug B; Røsjø H; Steine K; Geisler J; Gulati G; Omland T
    Circulation; 2021 Jun; 143(25):2431-2440. PubMed ID: 33993702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
    Morris PG; Dickler M; McArthur HL; Traina T; Sugarman S; Lin N; Moy B; Come S; Godfrey L; Nulsen B; Chen C; Steingart R; Rugo H; Norton L; Winer E; Hudis CA; Dang CT
    J Clin Oncol; 2009 Dec; 27(36):6117-23. PubMed ID: 19901120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
    Drafts BC; Twomley KM; D'Agostino R; Lawrence J; Avis N; Ellis LR; Thohan V; Jordan J; Melin SA; Torti FM; Little WC; Hamilton CA; Hundley WG
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):877-85. PubMed ID: 23643285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Physical Activity, Functional Capacity, and Cardiac Function during Breast Cancer Therapy.
    Bellissimo MP; Canada JM; Jordan JH; Ladd AC; Heiston EM; Brubaker P; Mihalko SL; Reding K; D Agostino R; O Connell N; Hackney MH; Weaver KE; Lesser GJ; Avis NE; Hundley WG
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1509. PubMed ID: 35775211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy.
    Jolly MP; Jordan JH; Meléndez GC; McNeal GR; D'Agostino RB; Hundley WG
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):59. PubMed ID: 28768517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Mass Change After Anthracycline Chemotherapy.
    Jordan JH; Castellino SM; Meléndez GC; Klepin HD; Ellis LR; Lamar Z; Vasu S; Kitzman DW; Ntim WO; Brubaker PH; Reichek N; D'Agostino RB; Hundley WG
    Circ Heart Fail; 2018 Jul; 11(7):e004560. PubMed ID: 29991488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer.
    Mabudian L; Reding K; D'Agostino RB; Heiston EM; Bellissimo MP; Olson K; Ntim WO; Klepin HD; Dressler EV; Moore T; Jordan JH; O'Connell NS; Ladd A; Weaver KE; Ky B; Wagner LI; Hackney MH; Lesser GJ; Hundley WG;
    Cardiooncology; 2024 Jun; 10(1):34. PubMed ID: 38845066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
    Yoon GJ; Telli ML; Kao DP; Matsuda KY; Carlson RW; Witteles RM
    J Am Coll Cardiol; 2010 Nov; 56(20):1644-50. PubMed ID: 21050974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
    Geisberg CA; Abdallah WM; da Silva M; Silverstein C; Smith HM; Abramson V; Mayer I; Means-Powell J; Freehardt D; White B; Lenihan D; Sawyer DB
    J Card Fail; 2013 Jan; 19(1):10-5. PubMed ID: 23273589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction.
    Nowsheen S; Aziz K; Park JY; Lerman A; Villarraga HR; Ruddy KJ; Herrmann J
    J Am Heart Assoc; 2018 Aug; 7(15):e008637. PubMed ID: 30371238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial.
    Perez EA; Suman VJ; Davidson NE; Kaufman PA; Martino S; Dakhil SR; Ingle JN; Rodeheffer RJ; Gersh BJ; Jaffe AS
    J Clin Oncol; 2004 Sep; 22(18):3700-4. PubMed ID: 15365066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
    Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect at One Year of Adjuvant Trastuzumab for HER2+ Breast Cancer Combined with Radiation or an Anthracycline on Left Ventricular Ejection Fraction.
    Andersen MM; Ayala-Peacock D; Bowers J; Kooken BW; D'Agostino RB; Jordan JH; Vasu S; Thomas A; Klepin HD; Brown DR; Hundley WG
    Am J Cardiol; 2020 Jun; 125(12):1906-1912. PubMed ID: 32331711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up.
    Narayan HK; Finkelman B; French B; Plappert T; Hyman D; Smith AM; Margulies KB; Ky B
    Circulation; 2017 Apr; 135(15):1397-1412. PubMed ID: 28104715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.